You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
漢鼎宇佑(300300.SZ):嶺外項目所屬土地房產被拍賣 預計對公司經營業績產生一定影響
格隆匯 12-25 21:08

格隆匯12月25日丨漢鼎宇佑(300300.SZ)公佈,公司與浙江易健生物製品有限公司(“易健生物”)經過業務洽商,於2015年5月19日簽訂了《諸暨市嶺外生物醫藥產業園區採購施工建設項目》合同(“嶺外項目”),公司負責該項目的機電安裝施工總承包工程。

2019年12月25日,公司通過阿里巴巴司法拍賣平台獲知易健生物諸暨市嶺外生物醫藥產業園區土地房產因易健生物小額貸款合同糾紛案被公開拍賣成交,對嶺外項目繼續進行的可能性產生重大影響,

由於嶺外項目所屬土地房產被拍賣,造成該項目繼續實施的可能性產生重大影響,預計對公司的經營業績產生一定影響。

為最大限度保護公司利益,公司與易健生物協商辦理新增應收款項、保證金支付的增信措施,並已安排法務部門及聘請第三方律師事務所,擬採取提起訴訟等必要法律手段,最大限度減少公司損失。鑑於公司未能獲取易健生物財務報表或負債數據,公司尚需對部分關鍵財務數據進行進一步核實,根據公司目前掌握的不完全信息,及綜合考慮訴訟、資產保全等應對措施,經初步測算,項目減值損失約4500-8500萬元,佔公司2018年度經審計的淨利潤的36.10%-68.19%,預計將對公司2019年度業績產生較大影響。同時公司已經啟動年報的預審工作,公司正準備全面評估、核實本項目情況,目前正抽調人員組成工作組對本項目進行全面減值測試工作,公司將依據法律法規的要求在報告期末對上述事項進行減值測試,針對嶺外項目對存貨、應收賬款、其他應收款進行更加全面、審慎的分析,確定相應的減值準備,最終數據需經公司年審會計師審計後確認。公司將嚴格按照法律法規的相關規定履行相應信息披露義務。後續,公司將加強嶺外項目進展情況跟蹤力度,關注新戰略投資者引進等影響本項目進展的重點事項。敬請投資者注意投資風險。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account